Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Jul-Aug;45(4):405-7.
doi: 10.4103/0253-7613.114998.

A case of thrombocytopenia caused by rifampicin and pyrazinamide

Rekha Bansal  1 , Parveen K Sharma, Aradhna Sharma
Affiliations
Case Reports

A case of thrombocytopenia caused by rifampicin and pyrazinamide

Rekha Bansal et al. Indian J Pharmacol. 2013 Jul-Aug.

Abstract

A 32-year-old male patient was diagnosed as having pulmonary tuberculosis and put on category II antitubercular regime since he had a history of antituberculosis treatment 10 years ago. Within 3 weeks, patient presented with ulcers in mouth, and blood picture confirmed thrombocytopenia. Rifampicin-induced thrombocytopenia was suspected and antitubercular treatment stopped. Patient improved and was re-exposed to the drugs one by one. After re-exposure with pyrazinamide, the platelet count decreased drastically and oral mucosal ecchymoses reappeared, while with rifampicin, thrombocytopenia was accompanied with petechiae on legs and forearms. Isoniazid, ethambutol, and streptomycin were continued.

Keywords: Antituberculosis treatment; ecchymoses; petechiae; thrombocytopenia.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil

Figures

Figure 1
Figure 1
Ecchymoses caused by pyrazinamide
Figure 2
Figure 2
Petechiae caused by rifampicin
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Blajchman MA, Lowry RC, Petil JE, Stradling P. Rifampicin induced immune thrombocytopenia. Br Med J. 1970;3:24–6. - PMC - PubMed
    1. The use of the WHO-UMC system for standardized case causality assessment. [Last accessed on 2012 Sep 30]. Accessed from: http://www.WHO-UMC.org/graphics/4409.pdf .
    1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharacol Ther. 1981;30:239–45. - PubMed
    1. Vipan WH. Quinine a cause of purpura. Lancet. 1865;2:37.
    1. Bassi L, Perna G, Silvestri LG. Antibodies against rifampicin in patients with tuberculosis after discontinuation of daily treatment. Am Rev Respir Dis. 1976;114:1189–90. - PubMed

Publication types

MeSH terms